Portfolio company
AMVKG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This joint venture provides a platform for discovering and developing therapeutic antibody candidates for biotechnology and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kisoji
The company develops antibody therapeutics and a discovery platform for oncology and immunology patients using artificial intelligence and transgenic mice.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
LabGenius
This biopharmaceutical company develops therapeutic antibodies using an automated protein engineering platform for pharmaceutical and biotechnology partners.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
AMYL THERAPEUTICS
The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.
VelaVigo
This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
ybiologics
The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.